Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1 Colorectal Neoplasms 1

Interventions

Bevacizumab 57 Cetuximab 50 Fluorouracil 45 Leucovorin 39 Oxaliplatin 38 pembrolizumab 33 Specimen Handling 27 Irinotecan 25 Magnetic Resonance Spectroscopy 17 Biopsy 17 Nivolumab 15 HMPL-013 13 Folfox protocol 13 Cisplatin 13 Capecitabine 13 trifluridine tipiracil drug combination 12 Panitumumab 12 Gemcitabine 12 Carboplatin 12 Pemetrexed 10 IFL protocol 9 encorafenib 8 balstilimab 8 Standard of Care 8 Paclitaxel 8 Early Intervention, Educational 8 130-nm albumin-bound paclitaxel 8 fludarabine 7 atezolizumab 7 Trifluridine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × leronlimab × 90 days × Clear all

NCT06699836 2026-05-18

CLOVER

CytoDyn, Inc.

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡